A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

被引：0
|
作者：
Martin-Antonio, Beatriz
Suarez-LLedo, Maria
Arroyes, Montserrat
Fernandez-Aviles, Francesc [1 ]
Martinez, Carmen
Rovira, Montserrat
Espigado, Ildefonso [2 ]
Gallardo, David [3 ]
Bosch, Anna [4 ]
Buno, Ismael [5 ]
Martinez-Laperche, Carolina [6 ]
Jimenez-Velasco, Antonio [7 ]
De La Camara, Rafael [8 ]
Brunet, Salut [9 ]
Nieto, Jose B. [10 ]
Urbano-Ispizua, Alvaro [11 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] ICO Hosp Josep Trueta, Girona, Spain
[4] Hosp Josep Trueta, Girona, Spain
[5] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[6] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[7] Hosp Carlos Haya, Malaga, Spain
[8] Hosp Univ De La Princesa, Madrid, Spain
[9] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[10] Hosp Morales Meseguer, Murcia, Spain
[11] IDIBAPS, Hosp Clin, Inst Hematol & Oncol, Barcelona, Spain
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.468.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
468
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Second Allogeneic Stem Cell Transplantation (allo-SCT) Using Reduced-Intensity Conditioning (RIC) for Acute Myeloid Leukemia (AML) Patients Who Relapsed Following a First RIC Allo-SCT: a Survey From the Acute Leukemia Working Party of EBMT
    Mohty, Mohamad
    Labopin, Myriam
    Finke, Jurgen
    Schmid, Christoph
    Kolb, H. J.
    Bacigalupo, Andrea
    Blaise, Didier
    Cornillon, Jerome
    Milpied, Noel
    Cabrera-Marin, J. R.
    Ciceri, Fabio
    Rocha, Vanderson
    Nagler, Arnon
    BLOOD, 2010, 116 (21) : 1414 - 1414
  • [22] Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Liu, Hongtao
    Artz, Andrew
    Larson, Richard A.
    Kosuri, Satyajit
    Stock, Wendy
    Bishop, Michael R.
    BLOOD, 2017, 130
  • [23] REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): LONG TERM RESULTS OF A DONOR vs NO DONOR COMPARISON
    Mohty, M.
    De Lavallade, H.
    El-Cheikh, J.
    Ladaique, P.
    Faucher, C.
    Fuerst, S.
    Vey, N.
    Coso, D.
    Stoppa, A. M.
    Gastaut, J. A.
    Chabannon, C.
    Blaise, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 14 - 14
  • [24] The role of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor vs. no donor comparison.
    de la Vallade, H
    Mohty, M
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Ladaique, P
    Chabannon, C
    Blaise, D
    BLOOD, 2004, 104 (11) : 640A - 640A
  • [25] Allogeneic stem cell transplantation (Allo-SCT) for Acute Lymphoblastic Leukemia (ALL) in adult patients - are we doing better?
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S103 - S104
  • [26] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute myeloid leukemia (AML): Long term results of a "Donor" versus "No donor" comparison.
    Mohty, Mohamad
    de Lavallade, Hugues
    El-Cheikh, Jean
    Ladaique, Patrick
    Faucher, Catherine
    Furst, Sabine
    Vey, Norbert
    Coso, Diane
    Stoppa, Anne-Marie
    Gastaut, Jean-Albert
    Chabannon, Christian
    Blaise, Didier
    BLOOD, 2007, 110 (11) : 331A - 331A
  • [27] Salvage Therapy with Hypomethylating Agents (HMA) and/or Lenalidomide (len) for Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation (allo-SCT)
    Singh, Meenu
    Dhakal, Binod
    Shrestha, Anuj
    Atallah, Ehab
    Carlson, Karen
    Pasquini, Marcelo C.
    Rein, Lisa
    Banerjee, Anjishnu
    Esselmann, Jean
    Ramirez, Sarah
    Zellner, Katie
    Essenmacher, Amber
    Hari, Parameswaran N.
    Michaelis, Laura C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S357 - S357
  • [28] G to C Transition At Position-173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)
    Romero, Damia
    Martin-Antonio, Beatriz
    Pratcorona, Marta
    Trujillo, Pablo
    Espigado, Ildefonso
    Gallardo, David
    Bosch, Anna
    Buno, Ismael
    Martinez-Laperche, Carolina
    Jimenz-Velasco, Antonio
    De La Camara, Rafael
    Brunet, Salut
    Nieto, Jose B.
    Roman, Jose
    Suarez-LLedo, Maria
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    BLOOD, 2011, 118 (21) : 1085 - 1085
  • [29] Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure
    Mohty, Mohamad
    Malard, Florent
    Blaise, Didier
    Milpied, Noel
    Socie, Gerard
    Huynh, Anne
    Oumedaly, Reman
    Yakoub-Agha, Ibrahim
    Furst, Sabine
    Guillaume, Thierry
    Tabrizi, Reza
    Delaunay, Jacques
    Moreau, Philippe
    Labopin, Myriam
    Chevallier, Patrice
    BLOOD, 2014, 124 (21)
  • [30] Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure
    Mohty, M.
    Malard, F.
    Blaise, D.
    Milpied, N.
    Socie, G.
    Huynh, A.
    Reman, O.
    Yakoub-Agha, I.
    Furst, S.
    Guillaume, T.
    Tabrizi, R.
    Delaunay, J.
    Moreau, P.
    Labopin, M.
    Chevallier, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S15 - S15
12345